FDA jeopardizes the lives of lung transplant recipients and in the process severely increases the cost to develop new immunosuppression.
Publication
, Journal Article
Klintmalm, GB; Kaplan, B; Kirk, AD
Published in: Am J Transplant
April 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Am J Transplant
DOI
EISSN
1600-6143
Publication Date
April 2019
Volume
19
Issue
4
Start / End Page
971 / 972
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Transplant Recipients
- Surgery
- Lung Transplantation
- Liver
- Immunosuppressive Agents
- Humans
- Drug Costs
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Klintmalm, G. B., Kaplan, B., & Kirk, A. D. (2019). FDA jeopardizes the lives of lung transplant recipients and in the process severely increases the cost to develop new immunosuppression. Am J Transplant, 19(4), 971–972. https://doi.org/10.1111/ajt.15215
Klintmalm, Goran B., Bruce Kaplan, and Allan D. Kirk. “FDA jeopardizes the lives of lung transplant recipients and in the process severely increases the cost to develop new immunosuppression.” Am J Transplant 19, no. 4 (April 2019): 971–72. https://doi.org/10.1111/ajt.15215.
Klintmalm GB, Kaplan B, Kirk AD. FDA jeopardizes the lives of lung transplant recipients and in the process severely increases the cost to develop new immunosuppression. Am J Transplant. 2019 Apr;19(4):971–2.
Klintmalm, Goran B., et al. “FDA jeopardizes the lives of lung transplant recipients and in the process severely increases the cost to develop new immunosuppression.” Am J Transplant, vol. 19, no. 4, Apr. 2019, pp. 971–72. Pubmed, doi:10.1111/ajt.15215.
Klintmalm GB, Kaplan B, Kirk AD. FDA jeopardizes the lives of lung transplant recipients and in the process severely increases the cost to develop new immunosuppression. Am J Transplant. 2019 Apr;19(4):971–972.
Published In
Am J Transplant
DOI
EISSN
1600-6143
Publication Date
April 2019
Volume
19
Issue
4
Start / End Page
971 / 972
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Transplant Recipients
- Surgery
- Lung Transplantation
- Liver
- Immunosuppressive Agents
- Humans
- Drug Costs
- 3204 Immunology